688506.SS
688506.SS
CNE100006FN4
SICHUAN BIOKIN PHARMACEUTICAL C
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 2.520.113.323 5.822.717.804
56.7%
Cost of Revenue 232.398.812 264.385.235
12.1%
Gross Profit 2.287.714.511 5.558.332.569
58.8%
3.031.076.727 1.814.673.283
67.0%
Operating Income -743.362.216 3.743.659.286
119.9%
Pretax Income -721.433.360 3.978.153.627
118.1%
Net Income Common Stockholders -1.053.617.854 3.707.504.556
128.4%
-- --
--
-- --
--
ende